Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.57 |
| ▸ | ELANE | P08246 | 1/20 | 0.57 |
| ▸ | CTSG | P08311 | 1/20 | 0.57 |
| ▸ | CTRC | Q99895 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | MGLL | Q99685 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.37 |
| ▸ | EP300 | Q09472 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10336238 | 0.87 | F2 (0.42) | F2ELANECTSGCTRCLMNA | |
| SCHEMBL9334188 | 0.85 | F2 (0.46) | F2ELANECTSGCTRCLMNA | |
| SCHEMBL14490041 | 0.80 | F2 (0.43) | F2ELANECTSGCTRCLMNA | |
| SCHEMBL27601313 | 0.79 | F2 (0.35) | F2ELANECTSGCTRC | |
| SCHEMBL1426468 | 0.78 | ELANE (0.48) | F2ELANECTSGCTRCLMNA | |
| SCHEMBL12927818 | 0.74 | F2 (1.00) | F2ELANECTSGCTRCLMNA | |
| SCHEMBL19103223 | 0.74 | F2 (0.35) | F2ELANECTSGCTRCLMNA | |
| SCHEMBL11086325 | 0.73 | TP53 (0.45) | F2ELANECTSGCTRC | |
| SCHEMBL1426485 | 0.73 | LMNA (0.41) | F2ELANECTSGCTRCLMNA | |
| SCHEMBL15784520 | 0.72 | F2 (0.41) | F2ELANECTSGCTRCLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3746489-A1 | PHOTOLABILE BARBITURATE COMPOUNDS | 3M Innovative Properties Company (US) | 2020-12-09 | — | — | EP | claimed |
| CN-111630072-A | Photolabile barbiturate compound | 3M创新有限公司 | 2020-09-04 | — | — | CN | claimed |
| WO-2019152187-A1 | PHOTOLABILE BARBITURATE COMPOUNDS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-08-08 | — | — | WO | claimed |
| US-8853297-B2 | Method and means for infiltrating enamel lesions | CHARITE UNIVERSITATSMEDIZIN BERLIN (DE) | 2014-10-07 | — | — | US | claimed |
| US-20090304622-A1 | METHOD AND MEANS FOR INFILTRATING ENAMEL LESIONS | CHARITE-UNIVERSITATSMEDIZIN BERLIN (DE) | 2009-12-10 | — | — | US | claimed |
| EP-2023884-A1 | METHOD AND MEANS FOR INFILTRATING ENAMEL LESIONS | Ernst Mühlbauer GmbH & Co.KG (DE) | 2009-02-18 | — | — | EP | claimed |
| WO-2007131725-A1 | METHOD AND MEANS FOR INFILTRATING ENAMEL LESIONS | CHARITE-UNIVERSITÄTSMEDIZIN BERLIN (DE) | 2007-11-22 | — | — | WO | claimed |
| CN-116635452-B | Free radically polymerizable crosslinking agent, curable composition, and adhesive therefrom | 3M INNOVATIVE PROPERTIES CO. (US) | 2026-05-26 | — | — | CN | disclosed |
| US-12600885-B2 | Composition including monomer with a carboxylic acid group, monomer with a hydroxyl group, an alkyl monomer, and crosslinker and related article and method | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2026-04-14 | — | — | US | disclosed |
| US-12497476-B2 | Antibacterial polymer particles, composition, and article | GC CORPORATION (JP) | 2025-12-16 | — | — | US | disclosed |
| EP-4652982-A1 | DENTAL RESTORATION MATERIAL COMPOSITION | GC R&D Corporation (JP) | 2025-11-26 | — | — | EP | disclosed |
| US-12398301-B2 | Adhesives comprising cyclic imide addition-fragmentation and adhesion agents | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-08-26 | — | — | US | disclosed |
| US-12378340-B2 | Crosslinkers and curable compositions including the same | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-08-05 | — | — | US | disclosed |
| US-6852775-B1 | Polymerizable dental compositions | 3M ESPE AG (DE) | 2005-02-08 | — | — | US | disclosed |
| US-20040254261-A1 | Dental composition | GC CORPORATION (JP) | 2004-12-16 | — | — | US | disclosed |
| EP-1462079-A1 | Dental composition | GC Corporation (JP) | 2004-09-29 | — | — | EP | disclosed |
| US-20030158288-A1 | Two-component dental materials having a low setting temperature | 3M DEUTSCHLAND GMBH (DE) | 2003-08-21 | — | — | US | disclosed |
| US-6288138-B1 | Dental adhesive kit | SUN MEDICAL CO., LTD. (JP) | 2001-09-11 | — | — | US | disclosed |
| US-6174935-B1 | Dental adhesive kit | GC CORPORATION (JP) | 2001-01-16 | — | — | US | disclosed |
| EP-0923924-A2 | Dental adhesive kit | SUN MEDICAL CO., LTD. (JP) | 1999-06-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12497476-B2 | Antibacterial polymer particles, composition, and article | PCNA, PARG, PUF60 | F2 1126/4885ELANE 1327/4885CTSG 955/4885 |
| US-12600885-B2 | Composition including monomer with a carboxylic acid group, monomer with a hydroxyl group, an alkyl monomer, and crosslinker and related article and method | RAD51, HACL2, COL2A1 | F2 655/4885ELANE 732/4885CTSG 4524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.